Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-017046

EVP, Head of R&D acquired 53,879 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Dupont Jakob EVP, Head of R&D 2021-03-01 Grant or award +53,879 100,129 D
Derivatives
Dupont Jakob EVP, Head of R&D 2021-03-01 Grant or award · Employee Stock Option (Right to Buy) +81,327 81,327 D
Loading xslF345X03/doc4.xml…